Analyst Price Targets — NAUT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 28, 2025 1:10 pm | — | Guggenheim | $2.50 | $1.30 | TheFly | Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim |
| June 27, 2024 6:11 am | Subbu Nambi | Guggenheim | $6.00 | $2.29 | StreetInsider | Guggenheim Starts Nautilus Biotechnology (NAUT) at Buy |
Latest News for NAUT
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NAUT.
U.S. House Trading
No House trades found for NAUT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.